ADALIMUMAB (HUMIRA®) INDUCED RECURRENT PERITONSILLAR ABSCESS IN A PATIENT WHO RECEIVED THREE DIFFERENT ANTI-TNF THERAPIES

İKİZ V.

17. Ulusal Acil Tıp Kongresi, 8th Intercontinental Emergency Medicine Congress, 8th International Critical Care and Emergency Medicine Congress, 14 October 2021, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Yozgat Bozok University Affiliated: Yes